ask="N/A"
ask_size="N/A"
average_daily_volume="462472"
bid="55.00"
bid_size="10000"
book_value="11.38"
change="+1.26"
change_from_200_day_moving_average="7.31"
change_from_50_day_moving_average="5.02"
change_from_52_week_high="-8.59"
change_From_52_week_low="31.66"
change_in_percent="+1.64%"
close="78.18"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-6.21"
ebitda="-244.98M"
eps_estimate_current_year="-7.07"
eps_estimate_next_quarter="-1.77"
eps_estimate_next_year="-6.40"
ex_dividend_date="N/A"
float_shares="37689000"
high="78.82"
high_52_weeks="86.77"
last_trade_date="2/22/2017"
last_trade_price="78.18"
last_trade_size="23810"
last_trade_time="4:00pm"
low="76.53"
low_52_weeks="46.52"
market_capitalization="3.19B"
moving_average_200_day="70.87"
moving_average_50_day="73.16"
name="Ultragenyx Pharmaceutical Inc."
notes="N/A"
one_year_target_price="94.50"
open="77.00"
pe_ratio="N/A"
peg_ratio="-0.37"
percent_change_from_200_day_moving_average="+10.32%"
percent_change_from_50_day_moving_average="+6.87%"
percent_change_from_52_week_high="-9.90%"
percent_change_from_52_week_low="+68.06%"
previous_close="76.92"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="6.76"
price_per_sales="23630.63"
revenue="133000.00"
shares_outstanding="40859000"
short_ratio="15.47"
stock_exchange="NMS"
symbol="RARE"
volume="362662"
weeks_range_52="46.52 - 86.77"
